Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0000899243-23-000990

Options or other derivatives

  • Director acquired 30,943 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tregoning Kathleen Director 2023-01-03 Grant or award · Stock Option (Right to Buy) +30,943 $1.29 $39,916 30,943 D
Loading xslF345X03/doc4.xml…